ReviewFrontiers in artificial intelligence2023
Machine learning algorithms in microbial classification: a comparative analysis.
Review in Frontiers in artificial intelligence, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Bibliometric analysis of the application of artificial intelligence techniques in bacteriology: a PRISMA-guided research agenda.Frontiers in microbiology · 2025Pooled it
- Artificial Intelligence in Foodborne Pathogen Detection from Sensing to Food Safety Systems: A Systematic Review.Foods (Basel, Switzerland) · 2026Review
- Identification and Screening of Lactate-Related Genes as Molecular Markers for Early Diagnosis of Steroid-Induced Osteonecrosis of the Femoral Head.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026Article
- Article
- Engineering of Synthetic Microbial Consortia for Sustainable Management of Wastewater and Polyethylene Terephthalate: A Comprehensive Review.International journal of molecular sciences · 2025Review
- MACNeXt-Based Bacteria Species Detection.Microorganisms · 2025Article
- Engineering Useful Microbial Species for Pharmaceutical Applications.Microorganisms · 2025Review
- Engineered probiotics for inflammatory bowel disease therapy: mechanisms, delivery strategies, and precision medicine.Frontiers in microbiology · 2025Review
- Enhancing AI microscopy for foodborne bacterial classification using adversarial domain adaptation to address optical and biological variability.Frontiers in artificial intelligence · 2025Article
- Lactate-related gene signatures as prognostic predictors and comprehensive analysis of immune profiles in nasopharyngeal carcinoma.Journal of translational medicine · 2024Article
- ANS-SCMC: A matrix completion method based on adaptive neighbourhood similarity and sparse constraints for predicting microbe-disease associations.Journal of cellular and molecular medicine · 2024Article
- Editorial: Detection, characterization, and management of plant pathogens.Frontiers in plant science · 2024Article
- A machine learning-based strategy to elucidate the identification of antibiotic resistance in bacteria.Frontiers in antibiotics · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This research paper presents an overview of contemporary machine learning methodologies and their utilization in the domain of healthcare and the prevention of infectious diseases, specifically focusing on the classification and identification of bacterial species. As deep learning techniques have gained prominence in the healthcare sector, a diverse array of architectural models has emerged. Through a comprehensive review of pertinent literature, multiple studies employing machine learning algorithms in the context of microbial diagnosis and classification are examined. Each investigation entails a tabulated presentation of data, encompassing details about the training and validation datasets, specifications of the machine learning and deep learning techniques employed, as well as the evaluation metrics utilized to gauge algorithmic performance. Notably, Convolutional Neural Networks have been the predominant selection for image classification tasks by machine learning practitioners over the last decade. This preference stems from their ability to autonomously extract pertinent and distinguishing features with minimal human intervention. A range of CNN architectures have been developed and effectively applied in the realm of image classification. However, addressing the considerable data requirements of deep learning, recent advancements encompass the application of pre-trained models using transfer learning for the identification of microbial entities. This method involves repurposing the knowledge gleaned from solving alternate image classification challenges to accurately classify microbial images. Consequently, the necessity for extensive and varied training data is significantly mitigated. This study undertakes a comparative assessment of various popular pre-trained CNN architectures for the classification of bacteria. The dataset employed is composed of approximately 660 images, representing 33 bacterial species. To enhance dataset diversity, data augmentation is implemented, followed by evaluation on multiple models including AlexNet, VGGNet, Inception networks, Residual Networks, and Densely Connected Convolutional Networks. The results indicate that the DenseNet-121 architecture yields the optimal performance, achieving a peak accuracy of 99.08%, precision of 99.06%, recall of 99.00%, and an F1-score of 98.99%. By demonstrating the proficiency of the DenseNet-121 model on a comparatively modest dataset, this study underscores the viability of transfer learning in the healthcare sector for precise and efficient microbial identification. These findings contribute to the ongoing endeavors aimed at harnessing machine learning techniques to enhance healthcare methodologies and bolster infectious disease prevention practices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.